Aha is able to access repositories of product licenses, product dossiers, phase 3 clinical development projects and medical technologies.
Aha can organise to carry out commercial, financial and strategic due diligence on behalf of clients.
Aha is able to work with companies seeking to enter the EU.
Aha has strong links to a network of Investor groups and co-development partners.
Aha carry out In-licensing, out-licensing and co-development activities of new products, new formulations and new technologies between EU, US and Asia.
Aha has access to an extensive team of experts in clinical development, clinical trial management, product technical upgrades, regulatory strategy and manufacturing expertise.
Aha can access a forward-thinking IP consultancy who deliver a commercially focused and pro-active service based on extensive industry experience.
Companies that have the intension to build, use an external suppliers of API and FDF or who have acquired a new manufacturing site may require external assessment or a plan to gain EU GMP approval.